ARTIFICIAL INTELLIGENCE-ASSISTED RADIOTHERAPY FOR PELVIC AND ABDOMINAL MALIGNANCIES: ASSESSING FEASIBILITY IN THE CONTEXT OF AFRICA‑SPECIFIC RISKS - Top-Institutions - MDSpire

ARTIFICIAL INTELLIGENCE-ASSISTED RADIOTHERAPY FOR PELVIC AND ABDOMINAL MALIGNANCIES: ASSESSING FEASIBILITY IN THE CONTEXT OF AFRICA‑SPECIFIC RISKS

  • By

  • Fiagbedzi, Emmanuel

  • Acquah, George Felix

  • Baidoo, Alhassan Mohammed

  • Osei- Poku, Linda

  • Pokoo-Aikins, Mark

  • Dery, Theresa

  • Agyabeng, Annette

  • Issahaku, Shirazu

  • Sackey, Theophilus Akumea

  • Adu-Poku, Mary

  • Sosu, Edem Kwabla

  • Tagoe, Samuel Nii Adu

  • Addison, Eric Clement Kotei

  • Hasford, Francis

  • Stoeva, Magdalena

  • May 1, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Radiation Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Radiation Oncology

  • #3

    University Hospital Zurich
    University Hospital Zurich

    Zurich, Switzerland

    Key Differentiators

    • Radiation Oncology

  • #4

    Yale School of Medicine
    Yale School of Medicine

    New Haven, Connecticut

    Key Differentiators

    • Radiation Oncology

  • #5

    University of Miami Sylvester Comprehensive Cancer Center
    University of Miami Sylvester Comprehensive Cancer Center

    Miami, Florida

    Key Differentiators

    • Radiation Oncology

Original Source(s)

ARTIFICIAL INTELLIGENCE-ASSISTED RADIOTHERAPY FOR PELVIC AND ABDOMINAL MALIGNANCIES: ASSESSING FEASIBILITY IN THE CONTEXT OF AFRICA‑SPECIFIC RISKS

  • by Fiagbedzi, Emmanuel , Acquah, George Felix, Baidoo, Alhassan Mohammed, Osei- Poku, Linda , Pokoo-Aikins, Mark , Dery, Theresa , Agyabeng, Annette , Issahaku, Shirazu , Sackey, Theophilus Akumea, Adu-Poku, Mary , Sosu, Edem Kwabla, Tagoe, Samuel Nii Adu, Addison, Eric Clement Kotei, Hasford, Francis , Stoeva, Magdalena

  • May 1, 2026

Related Content

Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry

Case Report: First description of an intracranial “NET” in ROHHAD syndrome; time to rename to the ROHHAD-NeCT syndrome?

Beyond inhibition: harnessing the DRD2–VEGF-A feedback loop for precision anti-angiogenesis therapy in cancer